Skip to main content

UBS Group AG

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in ORIC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,414,255
-$52,454 QoQ
Shares Held
222,923
+14.5% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 179 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ORIC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. ORIC ranks #202 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORIC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,414,255 222,923
2026-03-31 $2,466,709 194,689
2025-12-31 $6,011,138 734,858
2025-09-30 $4,070,832 339,236
2025-06-30 $1,004,910 99,006
2025-03-31 $443,822 79,538
2024-12-31 $604,677 74,929
2024-09-30 $733,437 71,555
2024-06-30 $571,305 80,807
2024-03-31 $1,293,338 94,061
2023-12-31 $376,951 40,973
2023-09-30 $104,495 17,272
2023-06-30 $172,798 22,268
2022-12-31 $26,110 4,433
2022-09-30 $425 133
2022-06-30 $9,873 2,204
2021-12-31 $917,264 62,399
2021-09-30 $543,366 25,986
2021-06-30 $128,057 7,239
2021-03-31 $771,848 31,504
2020-12-31 $51,688 1,527
2020-09-30 $40,266 1,610
2020-06-30 $95,928 2,844